18
Jun

A Phase III victory for Synergy Pharmaceuticals’ constipation drug has made the company an attractive takeout target, analysts say, with the acquisitive Valeant Pharmaceuticals a potential suitor.

…read more

Source: Synergy’s clinical success fuels the M&A rumor mill

    

0 No comments